Akebia Therapeutics, Inc. Prices Public Offering Of Common Stock

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (Nasdaq:AKBA) today announced the pricing of an underwritten public offering of 7,272,727 shares of common stock at a price to the public of $8.25 per share. The net proceeds of the offering are expected to be approximately $56.1 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by Akebia. The offering is expected to close on April 22, 2015, subject to the satisfaction of customary closing conditions.

Help employers find you! Check out all the jobs and post your resume.

Back to news